The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Rhona Stein

Garden State Cancer Center

Center for Molecular Medicine and Immunology

Belleville

NJ 07109

USA

[email]@gscancer.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Garden State Cancer Center, Center for Molecular Medicine and Immunology, Belleville, NJ 07109, USA. 2004 - 2010
  • Garden State Cancer Center, Belleville, New Jersey 07109, USA. 2003

References

  1. Therapy of B-cell malignancies by anti-HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways. Stein, R., Gupta, P., Chen, X., Cardillo, T.M., Furman, R.R., Chen, S., Chang, C.H., Goldenberg, D.M. Blood (2010) [Pubmed]
  2. Combining milatuzumab with bortezomib, doxorubicin, or dexamethasone improves responses in multiple myeloma cell lines. Stein, R., Smith, M.R., Chen, S., Zalath, M., Goldenberg, D.M. Clin. Cancer Res. (2009) [Pubmed]
  3. CD74: a new candidate target for the immunotherapy of B-cell neoplasms. Stein, R., Mattes, M.J., Cardillo, T.M., Hansen, H.J., Chang, C.H., Burton, J., Govindan, S., Goldenberg, D.M. Clin. Cancer Res. (2007) [Pubmed]
  4. Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases the potency of rituximab. Stein, R., Qu, Z., Chen, S., Solis, D., Hansen, H.J., Goldenberg, D.M. Blood (2006) [Pubmed]
  5. CD45 monoclonal antibody mediated cytolysis of human NK and T lymphoma cells. Stein, R. Haematologica (2006) [Pubmed]
  6. Advantage of a residualizing iodine radiolabel in the therapy of a colon cancer xenograft targeted with an anticarcinoembryonic antigen monoclonal antibody. Stein, R., Govindan, S.V., Hayes, M., Griffiths, G.L., Hansen, H.J., Horak, I.D., Goldenberg, D.M. Clin. Cancer Res. (2005) [Pubmed]
  7. Characterization of a new humanized anti-CD20 monoclonal antibody, IMMU-106, and Its use in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphoma. Stein, R., Qu, Z., Chen, S., Rosario, A., Shi, V., Hayes, M., Horak, I.D., Hansen, H.J., Goldenberg, D.M. Clin. Cancer Res. (2004) [Pubmed]
  8. Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies. Stein, R., Qu, Z., Cardillo, T.M., Chen, S., Rosario, A., Horak, I.D., Hansen, H.J., Goldenberg, D.M. Blood (2004) [Pubmed]
  9. A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy. Stein, R., Goldenberg, D.M. Mol. Cancer Ther. (2004) [Pubmed]
  10. Improved iodine radiolabels for monoclonal antibody therapy. Stein, R., Govindan, S.V., Mattes, M.J., Chen, S., Reed, L., Newsome, G., McBride, B.J., Griffiths, G.L., Hansen, H.J., Goldenberg, D.M. Cancer Res. (2003) [Pubmed]
 
WikiGenes - Universities